MB

Mark Bamforth

North America, Massachusetts, United States, Boston

Description

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investor Profile

Mark Bamforth has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (40%)
  • Seed (20%)
  • Series B (20%)
  • Series Unknown (20%)

Country Focus

  • United Kingdom (60%)
  • United States (40%)

Industry Focus

  • Biotechnology
  • Health Care
  • Machine Learning
  • Medical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Medical Device
  • Sensor
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mark Bamforth frequently co-invest with?

Scottish National Investment Bank
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Arranta Bio
North America, Massachusetts, United States, Watertown
Co-Investments: 1
L&
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Intuitive Investments Group
Europe, England, United Kingdom, London
Co-Investments: 1
SV
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
AE
Europe, Aberdeen City, United Kingdom, Aberdeen
Co-Investments: 1
Equity Gap
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Pillar VC
North America, Massachusetts, United States, Boston
Co-Investments: 1
NV
North America, Massachusetts, United States, Boston
Co-Investments: 1
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 3

Which angels does Mark Bamforth often collaborate with?

JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
PR
North America, Massachusetts, United States, Boston
Shared Deals: 1
JP
North America, United States
Shared Deals: 1
GC
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Mark Bamforth?

Thymmune Therapeutics

Cambridge, Massachusetts, United States

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

BiotechnologyTherapeutics
SeedMar 1, 2023
Amount Raised: $7,000,000
Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
Series AFeb 1, 2023
Amount Raised: $9,290,745
PneumoWave

Holytown, North Lanarkshire, United Kingdom

PneumoWave develops a respiratory sensor and monitoring platform to assist patients with respiratory conditions in managing their health.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical DeviceSensorTherapeutics
Series AJan 12, 2023
Amount Raised: $9,162,308
Talking Medicines

Glasgow, Glasgow City, United Kingdom

Talking Medicines is revolutionising healthcare marketing through AI/ML/NLP/GPT driven curated Patient, HCP and Opinion Leader insights

Artificial Intelligence (AI)Business IntelligenceData VisualizationHealth CareMachine LearningMedical
Series UnknownFeb 1, 2022
Amount Raised: $2,028,749
CONTINUUS Pharmaceuticals

Boston, Massachusetts, United States

Continuus Pharmaceuticals designs, builds, and runs manufacturing processes for pharmaceutical and generic clients.

BiotechnologyManufacturingMedicalPharmaceutical
Series BSep 5, 2019
Amount Raised: $5,000,000